Kerry aims to acquire part of Chr. Hansen and Novozymes’ lactase enzyme business

Kerry Group plc (Tralee, Ireland) announced plans to acquire part of the global lactase enzyme business belonging to Chr. Hansen Holding A/S and Novozymes A/S.

“The acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger-approval process,” Kerry’s press release notes.

The acquisition would boost Kerry’s enzyme technology to create lactose-free and reduced-sugar dairy products, the firm says. Kerry had already acquired enzyme manufacturers c-LEcta and Enmex. This latest acquisition would further bolster the company’s biotechnology capabilities.